DIISY News Alert Direct Line (DIISY) 18.2600 12/25/2014 18:1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Direct Line (DIISY) 18.2600 $DIISY

Household Insurance in the UK, Key Trends and Opportunities to 2018
M2 - Fri Dec 05, 3:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/9bh9md/household) has announced the addition of the "Household Insurance in the UK, Key Trends and Opportunities to 2018" report to their offering. This report is the result of extensive research into the household insurance industry in the UK, covering the market dynamics, competitive landscape and consumer perspectives through insights and forecasts. It also discusses key products and distribution channels and gives an overview of the leading companies in the category, along with details of strategic initiatives undertaken. Key Highlights: - Household insurance premiums fell in both 2012 and 2013. - The category has remained profitable despite the decline in premium. - Rising expenses and shift in distribution model threaten future profitability. - Direct Line Group remains the largest household insurer as mid-tier companies gain market share. - Premium growth is expected to settle at 1.2% by 2018. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Competitive Landscape 5 Porter's Five Forces Analysis 6 Deals and News 7 Regulation and Compliance 8 Consumer Perspective 9 Economic Backdrop 10 Company Profiles 11 Statistics Review Period 2009-2013 12 Appendix Companies Mentioned - Ace European Group Ltd - Ageas (UK) Ltd - Aviva Plc - Axa UK Plc - Direct Line Insurance Group Plc - Legal & General Group Plc - Lloyds Banking Group Plc - National Farmers Union Mutual Insurance Society - Royal & Sun Alliance Insurance Plc - Zurich Insurance Plc For more information visit http://www.researchandmarkets.com/research/9bh9md/household

Tracking The Hotchkis & Wiley Value Opportunities Fund - Q3 2014 Update
V is for Value - at Seeking Alpha - Mon Dec 01, 1:07PM CST

DOOR: 60.04 (-0.10), C: 54.54 (+0.12), BAC: 17.98 (+0.05), ORCL: 46.23 (+0.22), JPM: 62.48 (unch), AIG: 56.28 (-0.16), MSFT: 48.14 (-0.31)

Public and Product Liability Insurance in the UK, Key Trends and Opportunities to 2017
M2 - Tue Aug 05, 5:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kcw4fb/public_and) has announced the addition of the "Public and Product Liability Insurance in the UK, Key Trends and Opportunities to 2017" report to their offering. The public and product liability category grew at a compound annual growth rate (CAGR) of 8.8% during the 2009-2013 review period, reaching GBP2.9 billion in 2013. This growth was triggered by an increase in the number of personal injury compensation claims and the rising costs of medical care and civil litigation. Public and product liability insurance premiums increased by 8.6% in 2012, further rising by 19.5% in 2013. The strengthening economy, an increase in the number of private-sector businesses and a pick-up in retail and manufacturers' product sales have all contributed to premium growth in the category. Scope - This report provides a comprehensive analysis of the public and product liability insurance market in the UK. - It provides historical values for the UK public and products liability insurance market for the report's 2009-2013 review period and forecast figures for the 2014-2018 forecast period. - It offers estimates of gross written premiums generated in the market. - It provides an overview of claims, market dynamics and market drivers. - It profiles top public and product liability insurers in the UK and outlines the key challenges faced in the market. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Competitive Landscape 5 Porter's Five Forces Analysis 6 Deals and News 7 Regulation and Compliance 8 Economic Backdrop 9 Company Profiles 10 Statistics 11 Appendix Companies Mentioned: - ACE European Group Ltd - AIG Europe Ltd - Aviva Plc - Axa UK plc - Direct Line Insurance Group Plc - Great Lakes Reinsurance (UK) Plc - QBE Insurance (Europe) Ltd - Royal & Sun Alliance Insurance Plc - XL Group Plc - Zurich Insurance Plc For more information visit http://www.researchandmarkets.com/research/kcw4fb/public_and

Personal Accident and Health Insurance in the UK 2014-2018
M2 - Wed Jul 23, 8:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c2xbkk/personal_accident) has announced the addition of the "Personal Accident and Health Insurance in the UK, Key Trends and Opportunities to 2018" report to their offering. The UK personal accident and health insurance segment registered as the fastest growing in the industry, with a review-period (2009-2013) compound annual growth rate (CAGR) of 3.8%, despite low individual investments and consumer confidence levels as a result of the financial and debt crisis. The segment accounted for 3.4% of the total gross written premiums in 2013. Growth was partly attributed to an increase in outbound travel, rising healthcare expenditure, economic improvements and perceived inadequacies in the government-funded universal healthcare scheme, and growing awareness of the benefits of personal accident and health insurance. These factors, coupled with the rise in per capita annual disposable income and the aging population, are expected to support the segment over the forecast period (2013-2018). As such, the segment's gross written premium is projected to increase at a forecast-period CAGR of 2.3%. Key Highlights - The UK's personal accident and health insurance segment registered as the fastest growing in the industry, with a review-period (2009-2013) compound annual growth rate (CAGR) of 3.8%. - The country has both a public health service - the NHS - as well as private health system. - As of 2012, the NHS provided services to 85% of the population, while private health providers accounted for the remaining 15%. - The increasing trend towards private health insurance was due to long waiting times and limited availability of specialists who accept NHS patients. - In terms of gross written premium, the personal accident category accounted for the second-largest share of the personal accident and health segment in 2013, with 24.7%. - The UK travel insurance category is slowly recovering after a bad phase during the global economic slowdown. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Regional Market Dynamics 4 Personal Accident and Health Insurance Segment - Regional Benchmarking 5 UK Insurance Industry Attractiveness 6 Personal Accident and Health Insurance Outlook 7 Analysis by Distribution Channels 8 Porter's Five Forces Analysis - UK Personal Accident and Health Insurance 9 Reinsurance Growth Dynamics and Challenges 10 Governance, Risk and Compliance 11 Competitive Landscape and Strategic Insights 12 Business Environment and Country Risk 13 Appendix Companies Mentioned - AIG Europe Ltd - Aviva Plc - Axa UK Plc - Bupa (British United Provident Association) Ltd - Cigna Life Insurance Company of Europe - Direct Line Insurance Group Plc - Great Lakes Reinsurance (UK) Plc - Prudential Health - Simplyhealth Group Ltd - Western Provident Association Ltd For more information visit http://www.researchandmarkets.com/research/c2...l_accident

Non-Life Insurance in the UK - Key Trends and Opportunities to 2018
M2 - Wed Jul 23, 7:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zqwznt/nonlife) has announced the addition of the "Non-Life Insurance in the UK, Key Trends and Opportunities to 2018" report to their offering. The UK's non-life insurance segment was the second-largest in the country's insurance industry, accounting for 27.3% of the gross written premium in 2013. The UK's non-life segment was the fourth-largest in the world after the US, Japan and China in terms of gross written premium in 2012. The gross written premium of the non-life segment increased at a compound annual growth rate (CAGR) of 2.1% during the review period (2009-2013). The increase was partly due to country's infrastructure development, construction activities for the Olympic Games in 2012, rising car sales, and growing exports. Also, due to heavy flood losses in 2012 and 2013, companies recorded an increase in purchase of property insurance products that supported the growth of property insurance during the review period. Key Highlights - The UK's non-life insurance segment was the second-largest in the country's insurance industry, accounting for 27.3% of the gross written premium in 2013. - Insurers' growth will be challenged by continuing floods and extreme weather conditions in the country, which is expected to increase claims over the forecast period (2013-2018). - In 2013, property insurance accounted for 39.8% of non-life insurance gross written premium. - Due to heavy flood losses in 2012, companies recorded an increase in purchase of property and environmental impairment liability insurance. - The segment is fragmented, with the 10 leading insurers accounting for 62.0% of the total segment's gross written premiums in 2012. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Regional Market Dynamics 4 Non-Life Insurance Segment - Regional Benchmarking 5 UK Insurance Industry Attractiveness 6 Non-Life Insurance Outlook 7 Analysis by Distribution Channels 8 Porter's Five Forces Analysis - UK Non-Life Insurance 9 Reinsurance Growth Dynamics and Challenges 10 Governance, Risk and Compliance 11 Competitive Landscape and Strategic Insights 12 Business Environment and Country Risk Companies Mentioned - AIG Europe Ltd - Ageas (UK) Ltd - Allianz (UK) Ltd - Aviva Plc - Axa UK Plc - Bupa (British United Provident Association) Ltd - Direct Line Insurance Group Plc - Liverpool Victoria Insurance Company Ltd - RSA Insurance Group Plc - Zurich Insurance Co. (UK) Ltd For more information visit http://www.researchandmarkets.com/research/zqwznt/nonlife

United Kingdom Motor Insurance (Consumer) Market Report 2014-2018
M2 - Mon Jul 14, 9:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rmmbhl/motor_insurance) has announced the addition of the "Motor Insurance (Consumer) Market Report 2014" report to their offering. This Market Report covers the UK market for motor insurance, focusing on the consumer market; motor insurance for commercial vehicles is discussed in a separate report examining the wider commercial insurance sector as a whole. This publication will analyse the size of the market in terms of net written premiums (divided into comprehensive, non-comprehensive and motorcycle insurance) for the 5-year period between 2009 and 2013, as well as discussing future projections of the market until 2018. This report will also examine net claims incurred. The recent trends in the number of vehicles (cars and motorcycles) on British roads increased by 2.9% between 2009 and 2013, while the number of full driving licences in issue increased by 0.7% between 2012 and 2013. This means that, in 2013, over three-quarters of the population of Great Britain aged 17 and over are in possession of a driving licence. With the number of cars and licences in issue increasing, and given that motor insurance is compulsory, it is clear to see why motor insurance forms the largest proportion of the UK's general insurance sector, as well as being its backbone. Consumer motor insurance consistently makes up the lion's share of net written premiums in the UK. However, despite a rising number of cars and drivers, the past 12 months have seen a significant downward correction in the cost of premiums, particularly comprehensive premiums. This is on the back of the continuing rapid growth of price comparison websites (PCWs). Between 2009 and 2013, net written premiums for consumer motor insurance in the UK increased by 1.2%. There were sharp increases in 2010 and 2011, with premiums reaching a 5-year high in the latter year, before significant downward correction in premiums in 2012 and 2013 on the back of changes to legislation and regulation, as well as the wider use of products such as telematics insurance. This report forecasts that net written premiums in this sector will fall to a 10-year low in 2014, as premiums continue their current downward trend. Thereafter, with underwriting profits being threatened,it is believed that the market will grow by 17.2% between 2014 and 2018. Key Topics Covered: - Foreword - Executive Summary - Market Definition - Industry Background - Competitor Analysis - Strengths, Weaknesses, Opportunities and Threats - Current Issues - The Global Market - Forecasts - Company Profiles - Admiral Group Plc - Ageas Insurance Ltd - Allianz Insurance Plc - Aviva Plc - Axa Insurance Uk Plc - Comparethemarket.Com - Confused.Com - Direct Line Insurance Group Plc - Esure Group Plc - Gocompare.Com Ltd - Liverpool Victoria Insurance Company Ltd - Moneysupermarket.Com Group Plc - National Farmers Union Mutual Insurance Society Ltd (The) - RSA Insurance Group Plc For more information visit http://www.researchandmarkets.com/research/rm..._insurance

UK Travel Insurance Market Report 2014-2018
M2 - Fri Jul 11, 5:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gwbtr4/travel_insurance) has announced the addition of the "Travel Insurance Market Report 2014" report to their offering. This Market Report provides an overview of the market for travel insurance in the UK. Travel insurance is a voluntary type of general insurance sold to individuals or groups of individuals to insure against unexpected events which can occur while they are overseas. Generally, this involves claims for medical expenses, delayed departures and lost or stolen property. However, different travel insurers and different policies vary on the type of cover they provide. Profiles of a selection of some of the UK's largest insurers active in the provision of travel insurance are provided in this report. This report examines the market for travel insurance by analysing the travel trends of the UK's population, considering the number of overseas visits that take place each year and analysing the destinations of outbound UK travellers. The report also takes into account the demographics of the UK's population over the past 40 years and the way this has shifted, specifically relating to the age of the population and what this means for the travel insurance market. The market for travel insurance has seen considerable fluctuations over the past 5 years in terms of gross written premiums, with sharp declines noted in 2011 and 2012 alongside lower demand for travel during the economic downturn. Between 2009 and 2013, gross written premiums for travel insurance declined by 7.3% due to lower demand; however, growth of 7.7% was noted in 2013 on the back of improving outbound travel. In volume terms, the number of travel insurance policies written fell by 19.8% between 2009 and 2012, although an increase of 2.3% was noted in 2013. For the future, this publication forecasts that the value of the travel insurance market in the UK will increase by 11.6% between 2014 and 2018, as a resurgence in outbound travel occurs owing to the UK's improving economic fortunes. Much of this growth will be in the area of annual multi-trip policies, which will provide the engine for growth for the industry going forward. Key Topics Covered: - Foreword - Executive Summary - Market Definition - Market Size - Industry Background - Competitor Analysis - Strengths, Weaknesses, Opportunities and Threats - Buying Behaviour - Current Issues - The Global Market - Forecasts Company Profiles - AIG Europe Ltd - AXA Insurance UK PLC - Ageas Insurance Ltd - Aviva PLC - Cigna Insurance Services (Europe) Ltd - CompareTheMarket.com - Confused.com - Direct Line Insurance Group PLC - GoCompare.com Ltd - Liverpool Victoria Insurance Company Ltd - Mondial Assistance (UK) Ltd - MoneySupermarket.com Group PLC - RSA Insurance Group PLC - Saga Services Ltd - The British United Provident Association Ltd - The National Farmers Union Mut For more information visit http://www.researchandmarkets.com/research/gw..._insurance




Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 80

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 74

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 25

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: LifeMD Inc Faces Legal Investigation Risks

Updated Category News Views 167

Understanding Recent Developments for LifeMD, Inc. LifeMD, Inc. (NASDAQ: LFMD) is presently facing serious legal scrutiny following an investigation initiated by Faruqi & Faruqi, LLP. This renowned national securities law firm has stepped in to evaluate potential claims on behalf of investors. Investor Engagement Opportunities If you are among the investors who incurred...

Continue Reading
Value Stocks Poised for Growth Amid Market Shifts

Updated Category News Views 119

Value Stocks Set for Growth as Market Dynamics Change The stock market is currently experiencing a notable shift away from tech dominance. In recent months, tech stocks have faced challenges, raising questions about the potential revival of value stocks. This change in market sentiment is particularly evident in the impressive performance of the Value ETF, which has...

Continue Reading
EXEL Industries Reveals Key Share and Voting Rights Insights

Updated Category News Views 57

EXEL Industries Overview EXEL Industries is a prominent French Société Anonyme, with a robust share capital amounting to €16,969,750. The company has established a significant presence in the industry through its high standards and innovative products. Understanding Share Capital and Voting Rights On August 31, 2024, EXEL Industries provided updated insights regarding...

Continue Reading
Protective Life Corporation Strengthens Portfolio with Acquisition

Updated Category News Views 112

Protective Life Corporation Strengthens Its Portfolio In a significant development for Protective Life Corporation, the company has successfully completed the acquisition of ShelterPoint Group, Inc. Shielded under the corporate umbrella of Dai-ichi Life Holdings, Inc., Protective Life Corporation continues to solidify its position in the employee benefits industry. This...

Continue Reading
Safeguarding Your Personal Data in a Digital Health Era

Updated Category News Views 160

Understanding the Importance of Data Security in Health Tech As the holiday season approaches, consumers are excitedly purchasing various digital health tools such as fitness trackers, meditation apps, and smart scales. While these innovations can greatly enhance our wellness journey, they also raise significant concerns regarding the security of our personal data. Expert...

Continue Reading